C-type natriuretic peptide inhibits rat mesangial cell proliferation by a phosphorylation-dependent mechanism

Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):70-6. doi: 10.1007/pl00005140.

Abstract

We studied the effects of C-type natriuretic peptide (CNP) on rat cultured mesangial cell proliferation. (1) Exposure to CNP (10 nM-1 microM for 72 h) inhibited [3H]thymidine incorporation into mesangial cells in a concentration-dependent manner. Atrial natriuretic peptide (1 nM-1 microM), a peptide related to CNP, also decreased [3H]thymidine incorporation into these cells in a concentration-dependent manner. (2) Both CNP (10 nM- microM) and atrial natriuretic peptide (10 nM-1 microM) also decreased mesangial cell number. (3) The cyclic GMP analog, 8-bromo-cyclic GMP (100 microM and 1 microM), mimicked the inhibitory effects of CNP and atrial natriuretic peptide on [3H]thymidine incorporation into mesangial cells, whereas inhibitors of protein kinase C, protein kinase A, and protein kinase G reduced the effect of both natriuretic peptides. Moreover, the phosphatase inhibitor, calyculin A, increased [3H]thymidine incorporation into mesangial cells. (4) CNP and atrial natriuretic peptide decreased interleukin-1-, interleukin-6-, platelet derived growth factor-, angiotensin II-induced [3H]thymidine incorporation into mesangial cells. These results suggest that CNP exerts inhibitory effects on mesangial cell proliferation and that this effects depend on protein phosphorylation pathways.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II
  • Animals
  • Atrial Natriuretic Factor / antagonists & inhibitors
  • Atrial Natriuretic Factor / pharmacology*
  • Cell Count
  • Cell Division / drug effects
  • Cells, Cultured
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Glomerular Mesangium / drug effects*
  • Interleukin-1 / metabolism
  • Interleukin-6 / metabolism
  • Marine Toxins
  • Natriuretic Peptide, C-Type
  • Oxazoles / pharmacology
  • Phosphoprotein Phosphatases / antagonists & inhibitors
  • Phosphorylation
  • Platelet-Derived Growth Factor / metabolism
  • Protein Kinase C / antagonists & inhibitors
  • Proteins / antagonists & inhibitors
  • Proteins / pharmacology*
  • Rats
  • Thymidine / metabolism

Substances

  • Enzyme Inhibitors
  • Interleukin-1
  • Interleukin-6
  • Marine Toxins
  • Oxazoles
  • Platelet-Derived Growth Factor
  • Proteins
  • Angiotensin II
  • Natriuretic Peptide, C-Type
  • 8-bromocyclic GMP
  • calyculin A
  • Atrial Natriuretic Factor
  • Cyclic AMP-Dependent Protein Kinases
  • Protein Kinase C
  • Phosphoprotein Phosphatases
  • Cyclic GMP
  • Thymidine